Overall Technical outlook

Price Summary

On 2026-04-09, ERIS's stock started at 1344.0, reached a high of 1376.2, fell to 1327.2, and ended 1.5% up at 1364.1, with 34667 shares traded.
Over the previous 52 weeks, the stock reached a high of 1847.7 and a low of 0.0.
10 analysts suggest that ERIS's future price will lie between 1520.0 and 1940.0, with an average expected price of roughly 1743.6.

Technicals


Aroon: Aroon's bullish trend remains intact, with Aroon Up at the 100 level. This indicates strong market momentum, but a more comprehensive analysis using other indicators is required to assess the trend's strength and potential for continuation.
ERIS aroon 2af0d4
Aroon chart for Eris Lifesciences Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position for Eris Lifesciences Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
ERIS bbands 2af0d4
Bolinger Bands chart for Eris Lifesciences Limited


Parabolic SAR: The PSAR for ERIS continues to be bullish, establishing a crucial support level that may help maintain the current upward trend. This level of support suggests that the market is poised to continue its positive trajectory, offering a foundation for further growth.
ERIS psar 2af0d4
Parabolic Stop and Reverse chart for Eris Lifesciences Limited


Stochastic: The stochastic indicator is in a bullish position, with the K-line above both the D-line and the 80 level. This configuration suggests strong upward momentum, indicating that the market may continue its positive trend. Traders might view this as a sign of ongoing strength in the market.
ERIS stoch 2af0d4
Stochastic chart for Eris Lifesciences Limited


Tripple Moving Agerage: The 20-50-100 period moving averages are aligned for a bullish trend, but the slopes of the faster averages suggest that this strength may be fading for ERIS. The weakening momentum in these shorter-term averages hints that a reversal could be approaching, signaling that the current trend might not hold much longer.
ERIS trippleSMA 2af0d4
Tripple SMA chart for Eris Lifesciences Limited


To accurately interpret a company's technical data, it is important to first examine its fundamentals. These include financial performance, management quality, and growth prospects. In addition, understanding the dynamics of the industry in which the company operates—such as competition, market trends, and regulatory factors—provides further insights. This combined analysis helps create a fuller picture, allowing for more precise conclusions to be drawn from the company's technical performance and stock behavior.